AstraZeneca, Ranbaxy Settle Nexium Patent Dispute
AstraZeneca has reached a settlement with generics drugmaker Ranbaxy Laboratories Ltd., putting to rest their patent battle over the heartburn treatment Nexium....To view the full article, register now.
Already a subscriber? Click here to view full article